CHE was found to downregulate the expressions of MMP-2 and MMP-9 through the PI3K/Akt/mTOR signaling pathway and change the cytoskeleton structure by reducing p-FAK, which inhibited the metastasis and invasion of cancer in a dose-dependent manner (Zhu et al., 2018). The gene discussed is MMP2; the disease is cancer.